This article may be too technical for most readers to understand. Please help improve it to make it understandable to non-experts, without removing the technical details. (August 2012) (Learn how and when to remove this message)

Joel Sussman
Born	(1943-09-24) 24 September 1943 (age 81)
Nationality	Israeli
Alma mater	Cornell University MIT Hebrew University
Known for	Studies on acetylcholinesterase
Awards	Samuel and Paula Elkeles Prize (2005) Teva Founders' Award (2006)
Scientific career
Fields	Crystallography
Institutions	Weizmann Institute of Science

Joel L. Sussman (born September 24, 1943) is an Israeli crystallographer best known for his studies on acetylcholinesterase, a key protein involved in transmission of nerve signals. He is Professor Emeritus of Structural Biology at the Weizmann Institute of Science in Rehovot and is Co-Director of the Israel Structural Proteomics Center.

Sussman was born in Philadelphia, Pennsylvania.

In 1965, Sussman received his B.A. at Cornell University in math and physics. He received his PhD from MIT in biophysics in 1972, under Cyrus Levinthal. He postdocted at the Hebrew University of Jerusalem in 1972, with Yehuda Lapidot, and at Duke University in 1973-76 with Sung-Hou Kim.

Sussman has been a Professor at the Weizmann Institute of Science since 1976.

• 1984–85 – Head, Department of Structural Chemistry
• 1988–89 – Head, Kimmelman Center for Biomolecular Structure and Assembly
• 2002–14 – Incumbent of the Morton and Gladys Pickman Chair of Structural Biology
• 2016-now – Professor Emeritus

In 1994–99, he was also the director of the Protein Data Bank (PDB) at the Brookhaven National Laboratory.

Sussman was a pioneer of macromolecular refinement, developing CORELS and applying it to yeast tRNA^phe.^[1][2] He subsequently determined the structures of 'bulge'-containing DNA fragments as models for insertion mutations.^[3]

Sussman's current research focuses on nervous system proteins, especially acetylcholinesterase (AChE), whose 3D structure was first determined in his lab. This structure revealed:

• AChE is a prototype of the α/β hydrolase fold;^[4]
• π-cation interactions play a key role in binding of acetylcholine (ACh) and ligands to AChE;^[4]
• Its ACh-binding site assisted in structure-based design of promising leads for novel anti-Alzheimer's drugs;
• Discovered that the cytoplasmic portion of 'cholinesterase-like adhesion molecules' (CLAMs) are 'intrinsically disordered'^[5] that led to an algorithm, FoldIndex,^[6] for predicting whether a protein sequence will fold;
• The specific chemical and structural damage to proteins produced by synchrotron radiation, e.g. cleavage of a specific disulfide bond even at cryo temperatures.^[7]

He has investigated the molecular basis as to how proteins function under extreme conditions ^[8][9] with unexpected implications for kidney diseases. He determined the structures of Glucocerebrosidase,^[10] a protein defective in Gaucher disease, paving the way to novel therapeutic approaches, and of paraoxonase,^[11] a protein relevant to treatment of atherosclerosis.

• 2014 - Ilanit-Katzir Prize for exceptional achievements in the field of Life Sciences (together with Israel Silman)
• 2006 – Teva Founders' Award for breakthroughs in molecular medicine (together with Hermona Soreq and Israel Silman).
• 2005 – Honorary Professor, Chinese Academy of Sciences
• 2005 – Samuel and Paula Elkeles Prize for Outstanding Scientist in the field of medicine in Israel (together with Israel Silman)
• 1994 – Elected member, European Molecular Biology Organization (EMBO)

• Joel Sussman at the Weizmann Institute
• The Israel Structural Proteomics Center